This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe Spring
March 18–20, 2024 | Barcelona, SpainMarch 26–27, 2024 | Digital Partnering

StemcellX Limited


StemcellX was established with thew mission to bring a novel, stem cell-based regenerative treatment for Osteoarthritis (OA). We bring together a strong and experienced team from the UK and Europe to develop fully licensed products for the benefit of the millions of humans & animals suffering from chronic pain, caused by this debilitating disease.We have strong academic and industry partnerships in the UK, supporting our R&D programmes, including NGOs, Universities and independent professionals. We also have a highly experienced R&D operation and a purpose built, GMP compliant cell production facility in Hungary.Our first product, developed for dogs, is now entering final regulatory trials. Using our production technologies, we begun to develop a stem cell treatment for human Osteoarthritis and are currently pursuing a preclinical programme. The feasibility and effectiveness of our approach has recently been showcased by our treatment of an OA sufferer, elderly Gorilla in Budapest Zoo, the first ever primate to benefit from such medication. Since her treatment in August 2023, her quality of life has been transformed, demonstrating the safety and life-changing efficacy our stem cell products in one of our closest relatives.